Co-expression of Mlf^Scer\UAS.cKa with Dref^Scer\UAS.cSa in the eye under the control of Scer\GAL4^GMR.PF does not suppress the eye degeneration observed upon expression of Dref^Scer\UAS.cSa alone.

Expression of Mlf^Scer\UAS.cKa under the control of Scer\GAL4^GMR.PF suppresses the structural and pigmentation defects observed in Zzzz\CAG^{127Q.Scer\UAS.T:Ivir\HA1} mutants.

Retina expressing Mlf^Scer\UAS.cKa and pros^{Zzzz\CAG.20Q.Scer\UAS.T:Ivir\HA1} both under the control of Scer\GAL4^GMR.PF exhibit a normal morphology.

Retina expressing Mlf^Scer\UAS.cKa and pros^{Zzzz\CAG.127Q.Scer\UAS.T:Ivir\HA1} both under the control of Scer\GAL4^GMR.PF results in retinas that are thinner than wild-type and exhibit aberrant tissue morphology.

The presence of one or two copies of Mlf^Scer\UAS.cKa (with the Scer\GAL4^GMR.PF driver) suppresses the deterioration of eye structure found in flies expressing Hsap\HD^GMR.Q120.

The presence of one or two copies of Mlf^Scer\UAS.cKa (with the Scer\GAL4^GMR.PF driver) fails to suppress the deterioration of eye structure after 1 day post eclosion found in flies expressing pros^{Zzzz\CAG.127Q.Scer\UAS.T:Ivir\HA1}.

Expression of Mlf^Scer\UAS.cKa under the control of Scer\GAL4^Appl.G1a has a protective effect against Zzzz\CAG^{63Q.Scer\UAS.T:Ivir\HA1} toxicity. At day 20, 55% of flies expressing Zzzz\CAG^{63Q.Scer\UAS.T:Ivir\HA1} along with Mlf^Scer\UAS.cKa (both under the control of Scer\GAL4^Appl.G1a) are still active, while those expressing Zzzz\CAG^{63Q.Scer\UAS.T:Ivir\HA1} alone are dead.